147 related articles for article (PubMed ID: 17881539)
21. Genetic variations in the SOCS3 gene in patients with Graves' ophthalmopathy.
Yan R; Yang J; Jiang P; Jin L; Ma J; Huang R; Ma N; Jiang F
J Clin Pathol; 2015 Jun; 68(6):448-52. PubMed ID: 25770161
[TBL] [Abstract][Full Text] [Related]
22. Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
Abe H; Hayes CN; Ochi H; Tsuge M; Miki D; Hiraga N; Imamura M; Takahashi S; Kubo M; Nakamura Y; Kamatani N; Chayama K
J Med Virol; 2011 Sep; 83(9):1597-607. PubMed ID: 21739451
[TBL] [Abstract][Full Text] [Related]
23. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM
AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315
[TBL] [Abstract][Full Text] [Related]
24. Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b.
Yoshizawa K; Abe H; Aida Y; Ishiguro H; Ika M; Shimada N; Tsubota A; Aizawa Y
J Med Virol; 2013 Jul; 85(7):1180-90. PubMed ID: 23918536
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
26. IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.
Chen JY; Lin CY; Wang CM; Lin YT; Kuo SN; Shiu CF; Chang SW; Wu J; Sheen IS
Genes Immun; 2011 Jun; 12(4):300-9. PubMed ID: 21346780
[TBL] [Abstract][Full Text] [Related]
27. Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
Naeemi H; Aslam R; Raza SM; Shahzad MA; Naz S; Manzoor S; Khaliq S
Arch Virol; 2018 Apr; 163(4):997-1008. PubMed ID: 29340806
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
Hayashi K; Katano Y; Kuzuya T; Tachi Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Urano F; Yoshioka K; Toyoda H; Kumada T; Goto H
J Med Virol; 2012 Mar; 84(3):438-44. PubMed ID: 22246829
[TBL] [Abstract][Full Text] [Related]
29. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C.
Hung CH; Hu TH; Lu SN; Chen CH; Wang JH; Lee CM
J Formos Med Assoc; 2016 Apr; 115(4):278-83. PubMed ID: 26725771
[TBL] [Abstract][Full Text] [Related]
30. Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.
Lee CM; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH; Yen YH
J Formos Med Assoc; 2016 Jun; 115(6):440-4. PubMed ID: 26786212
[TBL] [Abstract][Full Text] [Related]
31. Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.
Ladero JM; Martin EG; Fernández C; Carballo M; Devesa MJ; Martínez C; Suárez A; Díaz-Rubio M; Agúndez JA
J Gastroenterol Hepatol; 2012 Feb; 27(2):279-85. PubMed ID: 21722179
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
[TBL] [Abstract][Full Text] [Related]
33. Association between
Yao Y; Liu M; Zang F; Yue M; Xia X; Feng Y; Fan H; Zhang Y; Huang P; Yu R
BMJ Open; 2018 Apr; 8(4):e019406. PubMed ID: 29654010
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
Yee LJ; Tang J; Gibson AW; Kimberly R; Van Leeuwen DJ; Kaslow RA
Hepatology; 2001 Mar; 33(3):708-12. PubMed ID: 11230752
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
Shaker OG; Sadik NA
J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
[TBL] [Abstract][Full Text] [Related]
36. Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.
Oze T; Hiramatsu N; Yakushijin T; Miyazaki M; Iio S; Oshita M; Hagiwara H; Mita E; Inui Y; Hijioka T; Inada M; Tamura S; Yoshihara H; Inoue A; Imai Y; Miyagi T; Yoshida Y; Tatsumi T; Kanto T; Kasahara A; Hayashi N; Takehara T
J Gastroenterol; 2014 Apr; 49(4):737-47. PubMed ID: 23689988
[TBL] [Abstract][Full Text] [Related]
37. Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study.
Shimada N; Toyoda H; Tsubota A; Ide T; Takaguchi K; Kato K; Kondoh M; Matsuyama K; Kumada T; Sata M
J Gastroenterol; 2014 Nov; 49(11):1485-94. PubMed ID: 24287582
[TBL] [Abstract][Full Text] [Related]
38. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.
Younossi ZM; Birerdinc A; Estep M; Stepanova M; Afendy A; Baranova A
J Transl Med; 2012 Feb; 10():25. PubMed ID: 22313623
[TBL] [Abstract][Full Text] [Related]
39. Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.
Yen YH; Wang JC; Hung CH; Lu SN; Wang JH; Hu TH; Kee KM; Hsiao CC; Lee CM
J Formos Med Assoc; 2015 Jul; 114(7):652-8. PubMed ID: 23810703
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.
Falleti E; Bitetto D; Fabris C; Fattovich G; Cussigh A; Cmet S; Ceriani E; Fornasiere E; Pasino M; Ieluzzi D; Pirisi M; Toniutto P
Hepatology; 2012 Nov; 56(5):1641-50. PubMed ID: 22610885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
